Restarting Dabigatran Etexilate 24 h After Reversal With Idarucizumab and Redosing Idarucizumab in Healthy Volunteers

被引：30

作者：

Glund, Stephan ^{[1
]}

Stangier, Joachim ^{[1
]}

van Ryn, Joanne ^{[1
]}

Schmohl, Michael ^{[1
]}

Moschetti, Viktoria ^{[1
]}

Haazen, Wouter ^{[1
]}

De Smet, Marina ^{[1
]}

Gansser, Dietmar ^{[1
]}

Norris, Stephen ^{[1
]}

Lang, Benjamin ^{[1
]}

Reilly, Paul ^{[1
]}

Kreuzer, Joerg ^{[1
]}

机构：

[1] Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 13期

关键词：

D O I：

10.1016/j.jacc.2016.01.043

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1654 / 1656

页数：4

共 3 条

[1] Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial [J].

Glund, Stephan ;

Stangier, Joachim ;

Schmohl, Michael ;

Gansser, Dietmar ;

Norris, Stephen ;

van Ryn, Joanne ;

Lang, Benjamin ;

Ramael, Steven ;

Moschetti, Viktoria ;

Gruenenfelder, Fredrik ;

Reilly, Paul ;

Kreuzer, Joerg .

LANCET, 2015, 386 (9994) :680-690

[2] Idarucizumab for Dabigatran Reversal [J].

Pollack, Charles V., Jr. ;

Reilly, Paul A. ;

Eikelboom, John ;

Glund, Stephan ;

Verhamme, Peter ;

Bernstein, Richard A. ;

Dubiel, Robert ;

Huisman, Menno V. ;

Hylek, Elaine M. ;

Kamphuisen, Pieter W. ;

Kreuzer, Jrg ;

Levy, Jerrold H. ;

Sellke, Frank W. ;

Stangier, Joachim ;

Steiner, Thorsten ;

Wang, Bushi ;

Kam, Chak-Wah ;

Weitz, Jeffrey I. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (06) :511-520

[3] A specific antidote for dabigatran: functional and structural characterization [J].

Schiele, Felix ;

van Ryn, Joanne ;

Canada, Keith ;

Newsome, Corey ;

Sepulveda, Eliud ;

Park, John ;

Nar, Herbert ;

Litzenburger, Tobias .

BLOOD, 2013, 121 (18) :3554-3562

← 1 →